Ascendis Pharma A/S (NasdaqGS:ASND) announces a share repurchase program. Under the program, the company will repurchase up to 300,000 American Depositary Shares, for $25 million. The purpose of the program is to acquire ADS needed in connection with the company’s planned share-based incentive program. The program is expected to end no later than December 31, 2021. The company expects to fund the program through its existing cash or cash equivalents.